High Flow Nasal Cannula Oxygen Therapy May Benefit Elderly Patients in ICU
After high flow nasal cannula oxygen therapy, 15% of patients had to be intubated and mechanically ventilated, but the majority stepped down to regular oxygen therapy.
CHEST 2018
Metered Dose Inhaler Errors Affect Many With COPD, Asthma
The most common error related to the use of metered dose inhalers was the failure to attach the inhaler to a spacer.
Cardiovascular Safety of Revefenacin as COPD Treatment Examined
No changes were observed in 12-lead electrocardiographic recordings associated with daily doses of revefenacin 88 μg and 175 μg in patients with COPD.
Amikacin Liposome Inhalation Plus Antibiotics Effective in MAC Lung Disease
Within 6 months, 23% of patients with Mycobacterium avium complex lung disease who had received add-on amikacin liposome inhalation suspension had a culture conversion.
Opioid Use Increases Likelihood of Intubation in COPD
Patients with chronic obstructive pulmonary disease who used opioids were more likely to be intubated during their hospitalization compared with nonopioid users
Lung Function Improved With Dupilumab in Adolescents With Asthma
Adolescents with asthma treated with dupilumab experienced significant improvements in FEV1 compared with placebo.
Omalizumab Improves Lung Function in Persistent Allergic Asthma
Patients with moderate to severe persistent allergic asthma who were treated with omalizumab experienced greater improvements in lung function after 16 weeks compared with those treated with placebo.
Pirfenidone Effective for Improving Pulmonary Fibrosis Symptoms
When treated with pirfenidone, patients with idiopathic pulmonary fibrosis experienced significant improvements in 6-minute walking distance and University of California San Diego Shortness of Breath Questionnaire scores.
High Treprostinil Doses Delay PAH-Related and All-Cause Hospitalizations
Higher doses of treprostinil significantly delayed time to first pulmonary arterial hypertension-related or all-cause hospitalization.
Severe Eosinophilic Asthma Effectively Managed With Benralizumab
Benralizumab was associated with a significant reduction in annual asthma exacerbation rates.
Want to read more?
Please login or register first to view this content.
